Dr. Mazzone and colleagues report on a cell-free DNA fragmentome assay (DELFIscore) for the classification of lung cancer (1). We have concerns and recommendations. Study participants were enrolled ...
We appreciate Dr. Tammemägi’s letter with regard to our recent article (1), but we disagree in some respects with his perspective and note a number of arithmetical and conceptual errors. Dr. Tammemägi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results